Pityriasis rubra pilaris (PRP), sometimes classified as a psoriasis variant, may involve the IL-23/Th17 axis, as suggested by its response to IL-17 and IL-23 therapies [8,9]. This evidence concerns the gene IL23A and psoriasis.